"Anti-Bacterial Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Substances that inhibit the growth or reproduction of BACTERIA.
Descriptor ID |
D000900
|
MeSH Number(s) |
D27.505.954.122.085
|
Concept/Terms |
Anti-Bacterial Agents- Anti-Bacterial Agents
- Agents, Anti-Bacterial
- Anti Bacterial Agents
- Antibacterial Agents
- Agents, Antibacterial
- Anti-Bacterial Compounds
- Anti Bacterial Compounds
- Compounds, Anti-Bacterial
Anti-Mycobacterial Agents- Anti-Mycobacterial Agents
- Agents, Anti-Mycobacterial
- Anti Mycobacterial Agents
- Antimycobacterial Agents
- Agents, Antimycobacterial
|
Below are MeSH descriptors whose meaning is more general than "Anti-Bacterial Agents".
Below are MeSH descriptors whose meaning is more specific than "Anti-Bacterial Agents".
This graph shows the total number of publications written about "Anti-Bacterial Agents" by people in this website by year, and whether "Anti-Bacterial Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 8 | 4 | 12 |
1995 | 9 | 4 | 13 |
1996 | 17 | 12 | 29 |
1997 | 19 | 6 | 25 |
1998 | 7 | 12 | 19 |
1999 | 12 | 12 | 24 |
2000 | 18 | 12 | 30 |
2001 | 13 | 13 | 26 |
2002 | 24 | 14 | 38 |
2003 | 32 | 32 | 64 |
2004 | 21 | 20 | 41 |
2005 | 32 | 23 | 55 |
2006 | 37 | 22 | 59 |
2007 | 26 | 37 | 63 |
2008 | 33 | 25 | 58 |
2009 | 33 | 33 | 66 |
2010 | 47 | 28 | 75 |
2011 | 49 | 31 | 80 |
2012 | 46 | 33 | 79 |
2013 | 51 | 38 | 89 |
2014 | 46 | 29 | 75 |
2015 | 43 | 39 | 82 |
2016 | 51 | 31 | 82 |
2017 | 60 | 35 | 95 |
2018 | 53 | 50 | 103 |
2019 | 64 | 51 | 115 |
2020 | 41 | 69 | 110 |
2021 | 31 | 69 | 100 |
2022 | 17 | 81 | 98 |
2023 | 9 | 77 | 86 |
2024 | 2 | 15 | 17 |
To return to the timeline,
click here.
Below are the most recent publications written about "Anti-Bacterial Agents" by people in Profiles.
-
Improving Sepsis Outcomes in the Era of Pay-for-Performance and Electronic Quality Measures: A Joint IDSA/ACEP/PIDS/SHEA/SHM/SIDP Position Paper. Clin Infect Dis. 2024 Mar 20; 78(3):505-513.
-
3D Printing of Alginate/Chitosan-Based Scaffold Empowered by Tyrosol-Loaded Niosome for Wound Healing Applications: In Vitro and In Vivo Performances. ACS Appl Bio Mater. 2024 Mar 18; 7(3):1449-1468.
-
Frequency of Treatment Failure of UTIs in Children With Congenital Urinary Tract Anomalies. Hosp Pediatr. 2024 Mar 01; 14(3):189-196.
-
Source tracking of extensively drug resistant Salmonella Typhi in food and raw vegetables using molecular approaches. J Infect Dev Ctries. 2024 Feb 29; 18(2):227-234.
-
Case series: Stenotrophomonas maltophilia in pediatric oncology patients. Cancer Rep (Hoboken). 2024 03; 7(3):e1982.
-
Antibacterial activity of ibezapolstat against antimicrobial-resistant clinical strains of Clostridioides difficile. Antimicrob Agents Chemother. 2024 Mar 06; 68(3):e0162123.
-
Phage therapy as a glimmer of hope in the fight against the recurrence or emergence of surgical site bacterial infections. Infection. 2024 Apr; 52(2):385-402.
-
LiaX is a surrogate marker for cell envelope stress and daptomycin non-susceptibility in Enterococcus faecium. Antimicrob Agents Chemother. 2024 Mar 06; 68(3):e0106923.
-
Invasive Group A Streptococcus in Infants Less Than 1-year of Age From 2012 to 2022: A Single-Center Experience. J Pediatric Infect Dis Soc. 2024 Jan 29; 13(1):110-113.
-
The mechanism of ceftazidime and cefiderocol hydrolysis by D179Y variants of KPC carbapenemases is similar and involves the formation of a long-lived covalent intermediate. Antimicrob Agents Chemother. 2024 Mar 06; 68(3):e0110823.